Is ztalmy used for cdkl5 deficiency?

What is ZTALMY, and is it approved for CDKL5 deficiency?

ZTALMY (ganaxolone) is used to treat seizures associated with CDKL5 deficiency disorder (CDD) in people 2 years of age and older. [1]

What condition does ZTALMY target in CDKL5 deficiency?

In CDKL5 deficiency disorder, ZTALMY is indicated for seizure treatment specifically in the setting of CDD-associated seizures. [1]

Are there age limits for ZTALMY in CDKL5 deficiency?

Yes. The indication in CDKL5 deficiency disorder is for patients age 2 years and older. [1]

Where can I verify the indication details?

You can check the labeled use and indication language at DrugPatentWatch.com. [1]

Sources

[1] https://www.drugpatentwatch.com/p/ztalmy